Open Access
Issue
Vet. Res.
Volume 40, Number 4, July-August 2009
Number of page(s) 14
DOI http://dx.doi.org/10.1051/vetres/2009023
Published online 24 April 2009
How to cite this article Vet. Res. (2009) 40:40
References of  Vet. Res. (2009) 40:40
  1. Bailey M., Stevens K., Bland P.W., Stokes C.R., A monoclonal antibody recognising an epitope associated with pig interleukin-2 receptors, J. Immunol. Methods (1992) 153:85–91 [CrossRef] [PubMed].
  2. Bhandari N., Sharma R.P., Fumonisin B(1)-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure, Toxicology (2002) 172:81–92 [CrossRef] [PubMed].
  3. Bhat R.V., Shetty P.H., Amruth R.P., Sudershan ., A foodborne disease outbreak due to the consumption of moldy sorghum and maize containing fumonisin mycotoxins, J. Toxicol. Clin. Toxicol. (1997) 35:249–255 [CrossRef] [PubMed].
  4. Bimczok D., Sowa E.N., Faber-Zuschratter H., Pabst R., Rothkötter H.J., Site-specific expression of CD11b and SIRPalpha (CD172a) on dendritic cells: implications for their migration patterns in the gut immune system, Eur. J. Immunol. (2005) 35:1418–1427 [CrossRef] [PubMed].
  5. Bimczok D., Doll S., Rau H., Goyarts T., Wundrack N., Naumann M., et al., The Fusarium toxin deoxynivalenol disrupts phenotype and function of monocyte-derived dendritic cells in vivo and in vitro, Immunobiology (2007) 212:655–666 [CrossRef] [PubMed].
  6. Bouhet S., Hourcade E., Loiseau N., Fikry A., Martinez S., Roselli M., et al., The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells, Toxicol. Sci. (2004) 77:165–171 [CrossRef] [PubMed].
  7. Bouhet S., Oswald I.P., The effects of mycotoxins fungal food contaminants, on the intestinal epithelial cell derived innate immune response, Vet. Immunol. Immunopathol. (2005) 108:199–209 [CrossRef] [PubMed].
  8. Bouhet S., Le Dorze E., Pérès S.Y., Fairbrother J.M., Oswald I.P., Mycotoxin fumonisin B1 selectively down-regulates basal IL-8 expression in pig intestine: in vivo and in vitro studies, Food Chem. Toxicol. (2006) 44:1768–1773 [CrossRef] [PubMed].
  9. Bouhet S., Oswald I.P., The intestine as a possible target for fumonisin toxicity, Mol. Nutr. Food. Res. (2007) 51:925–931 [CrossRef] [PubMed].
  10. Cox E., Houvenaghel A., Comparison of the in vitro adhesion of K88, K99, F41 and P987 positive Escherichia coli to intestinal villi of 4- to 5-week-old pigs, Vet. Microbiol (1993) 34:7–18 [CrossRef] [PubMed].
  11. Desai K., Sullards M.C., Allegood J., Wang E., Schmelz E.M., Hartl M., et al., Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis, Biochim. Biophys. Acta. (2002) 1585:188–189 [PubMed].
  12. Domeneghini C., Di Giancamillo A., Arrighi S., Bosi G., Gut-trophic feed additives and their effects upon the gut structure and intestinal metabolism State of the art in the pig, and perspectives towards humans, Histol. Histopathol. (2006) 21:273–283 [PubMed].
  13. Dom$\imath $'nguez J., Alvarez B., Alonso F., Thacker E., Haverson K., McCullough K., et al., Workshop studies on monoclonal antibodies in the myeloid panel with CD11 specificity, Vet. Immunol. Immunopathol. (2001) 80:111–119 [CrossRef] [PubMed].
  14. Haschek W.M., Gumprecht L.A., Smith G., Tumbleson M.E., Constable P.D., Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives, Environ. Health Perspect. (2001) 109:251–257 [CrossRef] [PubMed].
  15. Haverson K., Singha S., Stokes C.R., Bailey M., Professional and non-professional antigen-presenting cells in the porcine small intestine, Immunology (2000) 101:492–500 [CrossRef] [PubMed].
  16. Iwasaki A., Mucosal Dendritic Cells, Annu. Rev. Immunol. (2007) 25:381–418 [CrossRef] [PubMed].
  17. Johnson V.J., Sharma R.P., Gender-dependent immunosuppression following subacute exposure to fumonisin B1, Int. Immunopharmacol. (2001) 1:2023–2034 [CrossRef] [PubMed].
  18. Loiseau N., Debrauwer L., Sambou T., Bouhet S., Miller J.D., Martin P.G., et al., Fumonisin B1 exposure and its selective effect on porcine jejunal segment: sphingolipids glycolipids and trans-epithelial passage disturbance, Biochem. Pharmacol. (2007) 74:144–152 [CrossRef] [PubMed].
  19. Lunney J.K., Walker K., Goldman T., Aasted B., Bianchi A., Binns R., et al., Overview of the first international workshop to define swine leukocyte cluster of differentiation (CD) antigens, Vet. Immunol. Immunopathol. (1994) 43:193–206 [CrossRef] [PubMed].
  20. Maenetje P.W., Dutton M.F., The incidence of fungi and mycotoxins in South African barley and barley products, J. Environ. Sci. Health B (2007) 42:229–236 [CrossRef] [PubMed].
  21. Marin D.E., Gouze M.E., Taranu I., Oswald I.P., Fumonisin B1 alters cell cycle progression and interleukin-2 synthesis in swine peripheral blood mononuclear cells, Mol. Nutr. Food Res. (2007) 51:1406–1412 [CrossRef] [PubMed].
  22. Meissonnier G.M., Pinton P., Laffitte J., Cossalter A.M., Gong Y.Y., Wild C.P., et al., Immunotoxicity of aflatoxin B1: Impairment of cell-mediated response to vaccine antigen and modulation of cytokine expression, Toxicol. Appl. Pharmacol. (2008) 231:142–149 [CrossRef] [PubMed].
  23. Miller J.D., Aspects of the ecology of Fusarium toxins in cereals, Adv. Exp. Med. Biol. (2002) 504:19–27 [PubMed].
  24. Missmer S.A., Suarez L., Felkner M., Wang E., Merrill A.H. Jr., Rothman K.J., Hendricks K.A., Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border, Environ. Health Perspect. (2006) 114:237–241 [PubMed].
  25. Nikiema P.N., Worrillow L., Traore A.S., Wild C.P., Turner P.C., Fumonisin contamination of maize in Burkina Faso, West Africa, Food Addit. Contam. (2004) 21:865–870 [CrossRef] [PubMed].
  26. Oswald I., Comera C., Immunotoxicity of mycotoxins, Rev. Med. Vet. (1998) 149:585–590.
  27. Oswald I.P., Desautels C., Laffitte J., Fournout S., Peres S.Y., Odin M., et al., Mycotoxin fumonisin B1 increases intestinal colonization by pathogenic Escherichia coli in pigs, Appl. Environ. Microbiol. (2003) 69:5870–5874 [CrossRef] [PubMed].
  28. Peirson S.N., Butler J.N., Foster R., Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis, Nucleic Acids Res. (2003) 31:e73.
  29. Pescovitz M.D., Lunney J.K., Sachs D.H., Preparation and characterization of monoclonal antibodies reactive with porcine PBL, J. Immunol (1984) 33:368–375.
  30. Pestka J.J., Smolinski A.T., Deoxynivalenol: toxicology and potential effects on humans, J. Toxicol. Environ. Health B Crit. Rev. (2005) 8:39–69 [PubMed].
  31. Pinton P., Accensi F., Beauchamp E., Cossalter A.M., Callu P., Grosjean F., Oswald I.P., Ingestion of deoxynivalenol (DON) contaminated feed alters the pig vaccinal immune responses, Toxicol. Lett. (2008) 177:215–222 [CrossRef] [PubMed].
  32. Piva A., Casadei G., Pagliuca G., Cabassi E., Galvano F., Solfrizzo M., et al., Activated carbon does not prevent the toxicity of culture material containing fumonisin B1 when fed to weanling piglets, J. Anim. Sci. (2005) 83:1939–1947 [PubMed].
  33. Rasschaert K., Verdonck F., Goddeeris B.M., Duchateau L., Cox E., Screening of pigs resistant to F4 enterotoxigenic Escherichia coli (ETEC) infection, Vet. Microbiol. (2007) 123:249–253 [CrossRef] [PubMed].
  34. Royaee A.R., Husmann R.J., Dawson H.D., Calzada-Nova G., Schnitzlein W.M., Zuckermann F.A., Lunney J.K., Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination, Vet. Immunol. Immunopathol. (2004) 102:199–216 [CrossRef] [PubMed].
  35. Saalmüller A., Aasted B., Canals A., Dominguez J., Goldman T., Lunney J.K., et al., Analyses of mAb reactive with porcine CD8, Vet. Immunol. Immunopathol. (1994) 43:249–254 [CrossRef] [PubMed].
  36. Stockmann-Juvala H., Alenius H., Savolainen K., Effects of fumonisin B(1) on the expression of cytokines and chemokines in human dendritic cells, Food Chem. Toxicol. (2008) 46:1444–1451 [CrossRef] [PubMed].
  37. Taranu I., Marin D.E., Bouhet S., Pascale F., Bailly J.D., Miller J.D., et al., Mycotoxin fumonisin B1 alters the cytokine profile and decreases the vaccinal antibody titer in pigs, Toxicol. Sci. (2005) 84:301–307 [CrossRef] [PubMed].
  38. Theumer M.G., Lopez A.G., Masih D.T., Chulze S.N., Rubinstein H.R., Immunobiological effects of fumonisin B1 in experimental subchronic mycotoxicoses in rats, Clin. Diagn. Lab. Immunol. (2002) 9:149–155 [PubMed].
  39. Trinchieri G., Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nat. Rev. Immunol. (2003) 3:133–146 [CrossRef] [PubMed].
  40. Turley S.J., Inaba K., Garrett W.S., Ebersold M., Unternaehrer J., Steinman R.M., Mellman I., Transport of peptide-MHC class II complexes in developing dendritic cells, Science (2000) 288:522–527 [CrossRef] [PubMed].
  41. Van den Broeck W., Cox E., Goddeeris B.M., Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae, Infect. Immun. (1999) 67:520–526 [PubMed].
  42. Van den Broeck W., Cox E., Goddeeris B.M., Induction of immune responses in pigs following oral administration of purified F4 fimbriae, Vaccine (1999) 17:2020–2029 [CrossRef] [PubMed].
  43. Van Zaane D., Hulst M.M., Monoclonal antibodies against porcine immunoglobulin isotypes, Vet. Immunol. Immunopathol. (1987) 16:23–36 [CrossRef] [PubMed].
  44. Verdonck F., Cox E., van Gog K., Van der Stede Y., Duchateau L., Deprez P., Goddeeris B.M., Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain, Vaccine (2002) 20:2995–3004 [CrossRef] [PubMed].
  45. Verdonck F., Cox E., Van der Stede Y., Goddeeris B.M., Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and sstemic F4-specific immune response, Vaccine (2004) 22:4291–4299 [CrossRef] [PubMed].
  46. Verdonck F., Joensuu J.J., Stuyven E., De Meyer J., Muilu M., Pirhonen M., et al., The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization, Vaccine (2008) 26:5728–5735 [CrossRef] [PubMed].
  47. Von der Hardt K., Kandler M.A., Fink L., Schoof E., Dotsch J., Brandenstein O., et al., High frequency oscillatory ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets, Pediatr. Res. (2004) 55:339–346 [CrossRef] [PubMed].
  48. Whitaker T.B., Doko M.B., Maestroni B.M., Slate A.B., Ogunbanwo B.F., Evaluating the performance of sampling plans to detect fumonisin B1 in maize lots marketed in Nigeria, J. AOAC Int. (2007) 90:1050–1059 [PubMed].
  49. Yang H., Oura C.A., Kirkham P.A., Parkhouse R.M., Preparation of monoclonal anti-porcine CD3 antibodies and preliminary characterization of porcine T lymphocytes, Immunology (1996) 88:577–585 [CrossRef] [PubMed].
  50. Zhang W., Wen K., Azevedo M.S., Gonzalez A., Saif L.J., Li G., et al., Lactic acid bacterial colonization and human rotavirus infection influence distribution and frequencies of monocytes/macrophages and dendritic cells in neonatal gnotobiotic pigs, Vet. Immunol. Immunopathol. (2008) 121:222–231 [CrossRef] [PubMed].